Dual HER2 inhibition and paclitaxel in metastatic breast cancer

被引：0
|
作者：
Brower, Vicki
机构：
来源：
LANCET ONCOLOGY | 2015年 / 16卷 / 02期
关键词：
D O I：
10.1016/S1470-2045(14)71201-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E57 / E57
页数：1
相关论文
共 50 条
  • [41] Issues and controversies in the treatment of HER2 positive metastatic breast cancer
    Surabhi Amar
    Alvaro Moreno-Aspitia
    Edith A. Perez
    Breast Cancer Research and Treatment, 2008, 109 : 1 - 7
  • [42] Issues and controversies in the treatment of HER2 positive metastatic breast cancer
    Amar, Surabhi
    Moreno-Aspitia, Alvaro
    Perez, Edith A.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (01) : 1 - 7
  • [43] Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene
    Harbeck, Nadia
    Pegram, Mark D.
    Rueschoff, Josef
    Moebus, Volker
    BREAST CARE, 2010, 5 : 3 - 7
  • [44] Herceptin - For metastatic breast cancer tumors that overexpress the HER2 protein
    不详
    FORMULARY, 1998, 33 (11) : 1046 - 1047
  • [45] Outcome of non-metastatic HER2 positive breast cancer
    Mehmood, T.
    Rashid, A.
    Irfan, N.
    Hameed, S.
    Shah, M. Ali
    Jamshed, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S54 - S54
  • [46] Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer
    Knudsen, Anne-Dorthe Mosgaard
    Modvig, Mikala Wej
    Vogsen, Marianne
    Kodahl, Annette Raskov
    MEDICAL ONCOLOGY, 2024, 41 (05)
  • [47] HER2 as a prognostic factor in metastatic breast cancer treated with taxanes
    Parkes, E.
    McKenna, S. M.
    McAleer, J. J.
    Clarke, J.
    Clayton, A. J.
    James, C. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Application of Tucatinib and Trastuzumab: Dual Anti HER2 Therapy Against HER2 Positive Breast Cancer
    Sumanpreet Kaur
    Rajasri Bhattacharyya
    Dibyajyoti Banerjee
    Jaya Shukla
    Indian Journal of Clinical Biochemistry, 2021, 36 : 124 - 125
  • [49] Application of Tucatinib and Trastuzumab: Dual Anti HER2 Therapy Against HER2 Positive Breast Cancer
    Kaur, Sumanpreet
    Bhattacharyya, Rajasri
    Banerjee, Dibyajyoti
    Shukla, Jaya
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2021, 36 (01) : 124 - 125
  • [50] Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer
    Marin, Arnaldo
    Al Mamun, Abdullah
    Patel, Hima
    Akamatsu, Hiroaki
    Ye, Dan
    Sudhan, Dhivya R.
    Eli, Lisa
    Marcelain, Katherine
    Brown, Benjamin P.
    Meiler, Jens
    Arteaga, Carlos L.
    Hanker, Ariella B.
    CANCER RESEARCH, 2023, 83 (18) : 3145 - 3158
12345